Diabetic ketoacidosis associated with orlistat treatment.
Azar
S T
ST
Zantout
M S
MS
D000293:Adolescent; D019440:Anti-Obesity Agents / Q000009:adverse effects*; D003920:Diabetes Mellitus / Q000178:diet therapy / Q000188:drug therapy*; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology*; D016883:Diabetic Ketoacidosis / Q000139:chemically induced*; D004038:Diet, Reducing; D005260:Female; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D009765:Obesity; D000077403:Orlistat; D015430:Weight Gain
D019440:Anti-Obesity Agents; D007783:Lactones; D000077403:Orlistat